These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1941539)

  • 1. Physical factors contributing to the partition coefficient and retention time of 2',3'-dideoxynucleoside analogues.
    Lien EJ; Gao H; Prabhakar H
    J Pharm Sci; 1991 Jun; 80(6):517-21. PubMed ID: 1941539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemistry and anti-HIV properties of 2'-fluoro-2',3'-dideoxyarabinofuranosylpyrimidines.
    Siddiqui MA; Driscoll JS; Marquez VE; Roth JS; Shirasaka T; Mitsuya H; Barchi JJ; Kelley JA
    J Med Chem; 1992 Jun; 35(12):2195-201. PubMed ID: 1351945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer-assisted structure-activity correlations of halodideoxynucleoside analogs as potential anti-HIV drugs.
    Nasr M; Cradock J; Johnston MI
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):135-44. PubMed ID: 1540402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the lipophilicity of anti-HIV nucleoside analogues by determination of the partition coefficient and retention time on a Lichrospher 60 RP-8 HPLC column.
    Balzarini J; Cools M; De Clercq E
    Biochem Biophys Res Commun; 1989 Jan; 158(2):413-22. PubMed ID: 2916990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-assisted structure-activity correlations of dideoxynucleoside analogs as potential anti-HIV drugs.
    Nasr M; Litterst C; McGowan J
    Antiviral Res; 1990 Sep; 14(3):125-48. PubMed ID: 2080869
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and in vitro evaluation of some modified 4-thiopyrimidine nucleosides for prevention or reversal of AIDS-associated neurological disorders.
    Palomino E; Meltsner BR; Kessel D; Horwitz JP
    J Med Chem; 1990 Jan; 33(1):258-63. PubMed ID: 2153206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel 6-alkoxypurine 2',3'-dideoxynucleosides as inhibitors of the cytopathic effect of the human immunodeficiency virus.
    Burns CL; St Clair MH; Frick LW; Spector T; Averett DR; English ML; Holmes TJ; Krenitsky TA; Koszalka GW
    J Med Chem; 1993 Feb; 36(3):378-84. PubMed ID: 8426365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative structure-activity relationships and dipole moments of anticonvulsants and CNS depressants.
    Lien EJ; Liao RC; Shinouda HG
    J Pharm Sci; 1979 Apr; 68(4):463-5. PubMed ID: 438970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-nucleoside structures retain full anti-HCMV potency of the dideoxy furanopyrimidine family.
    Bidet O; McGuigan C; Snoeck R; Andrei G; De Clercq E; Balzarini J
    Antivir Chem Chemother; 2004 Nov; 15(6):329-32. PubMed ID: 15646646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retention of barbituric acid derivatives on immobilized artificial membrane stationary phase and its correlation with biological activity.
    Kepczyńska E; Bojarski J; Haber P; Kaliszan R
    Biomed Chromatogr; 2000 Jun; 14(4):256-60. PubMed ID: 10861737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of a dideoxynucleoside active against the HIV (AIDS) virus.
    Gulbis JM; MacKay MF; Holan G; Marcuccio SM
    Acta Crystallogr C; 1993 Jun; 49 ( Pt 6)():1095-7. PubMed ID: 8397977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli mediated biosynthesis and in vitro anti-HIV activity of lipophilic 6-halo-2',3'-dideoxypurine nucleosides.
    Murakami K; Shirasaka T; Yoshioka H; Kojima E; Aoki S; Ford H; Driscoll JS; Kelley JA; Mitsuya H
    J Med Chem; 1991 May; 34(5):1606-12. PubMed ID: 2033586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of uncoupling activity of substituted phenols with a physicochemical substituent and molecular parameters.
    Miyoshi H; Tsujishita H; Tokutake N; Fujita T
    Biochim Biophys Acta; 1990 Mar; 1016(1):99-106. PubMed ID: 2310745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anti-HIV activity of different sugar-modified pyrimidine and purine nucleosides.
    Herdewijn P; Balzarini J; Baba M; Pauwels R; Van Aerschot A; Janssen G; De Clercq E
    J Med Chem; 1988 Oct; 31(10):2040-8. PubMed ID: 3172142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of apio nucleosides as potential antiviral agents.
    Jeong LS; Moon HR; Hong JH; Yoo SJ; Choi WJ; Kim HO; Ahn HS; Baek HW; Chun MW; Kim HD; Kim J; Choi JR
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):657-60. PubMed ID: 11563085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiviral activity of monofluoro and difluoro analogues of pyrimidine deoxyribonucleosides against human immunodeficiency virus (HIV-1).
    Martin JA; Bushnell DJ; Duncan IB; Dunsdon SJ; Hall MJ; Machin PJ; Merrett JH; Parkes KE; Roberts NA; Thomas GJ
    J Med Chem; 1990 Aug; 33(8):2137-45. PubMed ID: 2165161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro models to predict the in vivo mechanism, rate, and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus.
    Tuntland T; Odinecs A; Pereira CM; Nosbisch C; Unadkat JD
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):198-206. PubMed ID: 9914604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of acyclic 3-[(2-hydroxyethoxy)methyl] analogues of antiviral furo- and pyrrolo[2,3-d]pyrimidine nucleosides.
    Janeba Z; Balzarini J; Andrei G; Snoeck R; De Clercq E; Robins MJ
    J Med Chem; 2005 Jul; 48(14):4690-6. PubMed ID: 16000005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple regression analysis with optimal molecular descriptors.
    Randic M; Basak SC
    SAR QSAR Environ Res; 2000; 11(1):1-23. PubMed ID: 10768403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between n-octanol/water partition coefficient and liquid chromatographic retention for caffeine and its metabolites, and some structure-pharmacokinetic considerations.
    Gaspari F; Bonati M
    J Pharm Pharmacol; 1987 Apr; 39(4):252-60. PubMed ID: 2884287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.